A detailed history of Mc Ilrath & Eck, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 91 shares of ZTS stock, worth $15,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 19 378.95%
Holding current value
$15,907
Previous $3,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $11,928 - $14,395
72 Added 378.95%
91 $15,000
Q4 2023

Feb 05, 2024

BUY
$151.44 - $200.09 $2,877 - $3,801
19 New
19 $3,000
Q1 2022

May 11, 2022

SELL
$181.39 - $234.03 $906 - $1,170
-5 Closed
0 $0
Q2 2020

Aug 04, 2020

SELL
$111.92 - $142.53 $4,364 - $5,558
-39 Reduced 88.64%
5 $1,000
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $4,077 - $6,377
44 New
44 $5,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Mc Ilrath & Eck, LLC Portfolio

Follow Mc Ilrath & Eck, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.